BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 35192151)

  • 21. Melanocortin signaling is decreased during neurotoxin-induced transient hyperphagia and increased body-weight gain.
    Dube MG; Pu S; Kalra SP; Kalra PS
    Peptides; 2000 Jun; 21(6):793-801. PubMed ID: 10958999
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel homozygous leptin receptor mutation in an infant with monogenic obesity.
    Boro H; Bundela V; Mannar V; Nagendra L; Jain V; Jain B; Kumar S; Agstam S
    Pediatr Endocrinol Diabetes Metab; 2023; 29(2):118-123. PubMed ID: 37728464
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rare genetic forms of obesity: From gene to therapy.
    Clément K; Mosbah H; Poitou C
    Physiol Behav; 2020 Dec; 227():113134. PubMed ID: 32805220
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Setmelanotide: what does it mean for clinical care of patients with obesity?
    Ryan DH
    Lancet Diabetes Endocrinol; 2020 Dec; 8(12):933-935. PubMed ID: 33137294
    [No Abstract]   [Full Text] [Related]  

  • 25. Structural analysis of setmelanotide binding to MC4R variants in comparison to wild-type receptor.
    Hammad MM; Mohammad A; Alam-Eldin N; Madhu D; Al-Mulla F; Abu-Farha M; Abubaker J
    Life Sci; 2022 Oct; 307():120857. PubMed ID: 35931197
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The efficacy and safety of setmelanotide in individuals with Bardet-Biedl syndrome or Alström syndrome: Phase 3 trial design.
    Haws RM; Gordon G; Han JC; Yanovski JA; Yuan G; Stewart MW
    Contemp Clin Trials Commun; 2021 Jun; 22():100780. PubMed ID: 34013094
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Narrative of a Patient with Leptin Receptor Deficiency: Personalized Medicine for a Rare Genetic Obesity Disorder.
    Welling MS; Kleinendorst L; van Haelst MM; van den Akker ELT
    Obes Facts; 2023; 16(5):514-518. PubMed ID: 37393902
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The melanocortin pathway and energy homeostasis: From discovery to obesity therapy.
    Yeo GSH; Chao DHM; Siegert AM; Koerperich ZM; Ericson MD; Simonds SE; Larson CM; Luquet S; Clarke I; Sharma S; Clément K; Cowley MA; Haskell-Luevano C; Van Der Ploeg L; Adan RAH
    Mol Metab; 2021 Jun; 48():101206. PubMed ID: 33684608
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Leptin receptor-positive and leptin receptor-negative proopiomelanocortin neurons innervate an identical set of brain structures.
    Lima LB; Metzger M; Furigo IC; Donato J
    Brain Res; 2016 Sep; 1646():366-376. PubMed ID: 27321158
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pro-opiomelanocortin (POMC) deficiency and peripheral melanocortins in obesity.
    Zemel MB; Shi H
    Nutr Rev; 2000 Jun; 58(6):177-80. PubMed ID: 10885325
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hormone-Replacement Therapy for Melanocyte-Stimulating Hormone Deficiency.
    Reitman ML
    N Engl J Med; 2016 Jul; 375(3):278-9. PubMed ID: 27468065
    [No Abstract]   [Full Text] [Related]  

  • 32. Functional characterization of all missense variants in
    Shah BP; Sleiman PM; Mc Donald J; Moeller IH; Kleyn P
    Expert Rev Endocrinol Metab; 2023 Mar; 18(2):209-219. PubMed ID: 36864747
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Two Cases With an Early Presented Proopiomelanocortin Deficiency-A Long-Term Follow-Up and Systematic Literature Review.
    Gregoric N; Groselj U; Bratina N; Debeljak M; Zerjav Tansek M; Suput Omladic J; Kovac J; Battelino T; Kotnik P; Avbelj Stefanija M
    Front Endocrinol (Lausanne); 2021; 12():689387. PubMed ID: 34177811
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A rapidly acting glutamatergic ARC→PVH satiety circuit postsynaptically regulated by α-MSH.
    Fenselau H; Campbell JN; Verstegen AM; Madara JC; Xu J; Shah BP; Resch JM; Yang Z; Mandelblat-Cerf Y; Livneh Y; Lowell BB
    Nat Neurosci; 2017 Jan; 20(1):42-51. PubMed ID: 27869800
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolic Precision Medicines: Curing POMC Deficiency.
    Müller TD; Tschöp MH; O'Rahilly S
    Cell Metab; 2016 Aug; 24(2):194-5. PubMed ID: 27452145
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The central melanocortin system and the integration of short- and long-term regulators of energy homeostasis.
    Ellacott KL; Cone RD
    Recent Prog Horm Res; 2004; 59():395-408. PubMed ID: 14749511
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Collective and individual functions of leptin receptor modulated neurons controlling metabolism and ingestion.
    van de Wall E; Leshan R; Xu AW; Balthasar N; Coppari R; Liu SM; Jo YH; MacKenzie RG; Allison DB; Dun NJ; Elmquist J; Lowell BB; Barsh GS; de Luca C; Myers MG; Schwartz GJ; Chua SC
    Endocrinology; 2008 Apr; 149(4):1773-85. PubMed ID: 18162515
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Setmelanotide: A Novel Targeted Treatment for Monogenic Obesity.
    Pressley H; Cornelio CK; Adams EN
    J Pharm Technol; 2022 Dec; 38(6):368-373. PubMed ID: 36311304
    [No Abstract]   [Full Text] [Related]  

  • 39. [Melanocortin peptides : Fundamentals, translational research, clinical dermatology, and future perspectives].
    Böhm M
    Hautarzt; 2020 Oct; 71(10):741-751. PubMed ID: 32880662
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.